about
Clinical, pathological and sonographic characteristics of unexpected gallbladder carcinoma.Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network.Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma.Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent.Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder.Impact of pre-operative positron emission tomography in gallbladder cancerDiagnosis and management of gallbladder cancer.Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladderAssociation of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer.PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma.Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancerIncreased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinomaMCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.Gallbladder cancer: epidemiology and outcome.The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancerGallbladder cancer: can newer insights improve the outcome?miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells.SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.A Month for Gallbladder Cancer: A Case Report of Four Gallbladder Cancers Over a 30-Day Period at a Community HospitalGallbladder carcinoma: Prognostic factors and therapeutic options.ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.Prognostic value of TROP2 expression in patients with gallbladder cancer.Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy.Paxillin and carbonic anhydrase IX are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma.Outcomes and prognostic factors in gallbladder cancer: a single-centre experience.Squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder: an immunohistochemistry study of prognostic markers.Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.Association between glutathione S-transferase M1 null genotype and risk of gallbladder cancer: a meta-analysis.ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.Gallbladder cancer
P2860
Q30402990-2A93E52F-1DAC-4686-A7A7-BD471F9C7167Q33672198-A8F98AED-DA03-4B89-8B77-F9A3CB82FF79Q34180209-5022321B-BFA1-4697-A14A-B1F941C77311Q34540184-AB7DD109-E154-4CA4-BDDA-F8F808F9AE09Q35576576-C1865D03-01AA-4D10-973D-DD26173C450AQ35805873-34F999C1-4A5F-4821-A933-2073A2278D80Q36132324-4D8B66E3-B044-47D0-AF9D-F11E9D101B6EQ36529907-7CD054A2-4148-4D1D-817C-FBD269BA2F7CQ36835253-73891B61-6C65-4FCD-851A-A50A9755A970Q36990673-9E2457E3-A12D-49C2-A63E-27EE725D5CDEQ37104978-3B355574-C06C-4408-BB4D-9E4338337FBDQ37176623-CFD91545-DB82-4C49-8B68-5DEE0468901CQ37313015-18ACF14F-2078-487D-B138-22052F716AFFQ37403517-F76EFA6A-409A-49DA-BC2F-62186DF644F1Q37635412-869201E6-B29A-4347-9E54-9AF0386CE4C3Q37746036-5A9E3364-67E6-4C23-B03E-54D1D0A23B2FQ37968331-0FCA9D83-A1FA-413C-B3B3-FBF815222E68Q39089969-29F761B1-7EB0-4B53-A4E6-CCC978F2D6F1Q40662726-7BC635BB-056C-4EA4-AF5E-0F5DD55ECEECQ41808414-2599FFB3-F6FF-4D14-94F0-03B488842D08Q43169383-865BA715-7B23-43DA-A000-053FC84C435AQ43461210-D9DB75AF-5094-49C3-B2D5-2862A723EED9Q43690229-490D9D50-5531-4B73-B07F-46163F769875Q44235056-6724D8FC-60E6-4C2D-9D8E-E5283A7940E3Q44506519-3ADD4085-FC97-4E34-80DC-A5AEE55A5C33Q44592465-D0CF5189-8BF8-407B-A4AF-C8DEE988CD81Q44616724-2D9748D0-7AAF-42C0-ABB2-172F9CB9C4DDQ44671372-EA2FF7BF-9874-4AC2-B248-1C4D19F31056Q45266873-D1375281-D7B4-42E7-89F3-2606539BFD14Q45399331-864FB5D4-88D7-4544-ADE4-6671E1BB8547Q45823417-8D55718D-DC36-4CA2-B384-CE5ECF582AD5Q50086229-227110FC-53F2-4654-A9B0-6812086D1D48Q50173842-67E55B73-7861-4A48-9CB6-7222E8E38E13Q50176110-18405C43-F612-4A4E-8745-A05F14E0BA66Q50177004-76DBD1B1-B158-43CF-A8E2-BBA093D9149FQ50178323-62FFCA33-9BB0-4F7F-AE0E-D464F02AD159Q53128298-BE0054F1-DFBF-4884-8223-C063ACC90E6AQ55070671-DAF8F883-68AD-49E8-8051-0FB519F16B33Q57653775-13F41CB7-64C0-4F49-85E8-E2EC6B456E35
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of gallbladder cancer.
@en
Management of gallbladder cancer.
@nl
type
label
Management of gallbladder cancer.
@en
Management of gallbladder cancer.
@nl
prefLabel
Management of gallbladder cancer.
@en
Management of gallbladder cancer.
@nl
P1476
Management of gallbladder cancer.
@en
P2093
Shiva Jayaraman
William R Jarnagin
P304
P356
10.1016/J.GTC.2010.02.006
P577
2010-06-01T00:00:00Z